Skip to content

Optical coherence tomography angiography (OCTA) of polypoidal choroidal vasculopathy (PCV)

Optical coherence tomography angiography (OCTA) of polypoidal choroidal vasculopathy (PCV)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20201015005
Enrollment
30
Registered
2020-10-15
Start date
2019-11-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polypoidal choroidal vasculopathy

Interventions

Patients already diagnosed with PCV and confirmed by visualization of polys by ICGA
Other
PCV patients

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age of at least 18 years old 2. Patients already diagnosed with PCV and confirmed by visualization of polys by ICGA 3. Patients with available OCTA images at the same period of ICGA (on the same day (if available) or may be on later days given that there are no significant changes in clinical signs seen on fundus photography and no laser or intravitreal treatments had been started).

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Significant ocular media opacity precluding adequate imaging signals. 3. Patients with other maculopathies that confound the visualization of PCV lesions

Design outcomes

Primary

MeasureTime frame
characteristic of polyps at the time of diagnosis Optical Coherent Tomogram Angiography

Secondary

MeasureTime frame
The mean anti-factor Xa levels in both groups 1 year mean as IU/ml

Contacts

Public ContactNopasak Phasukkijwatana

Faculty of Medicine Siriraj Hospital, Mahidol University

nopasak.sioph@gmail.com+66817140889

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026